Follow Us On
Facebook  Linkedin  X  

DID YOU KNOW?

Utilization of Interventional Techniques shows an exponential decline from 2019 to 2022:


Overall:

  • 28.9% decrease from 2019-2022, with a 10.7% geometric average annual change.


Epidural Services:

  • 24.7% decrease from 2019-2022, with a 9.0% geometric average annual change.


Facet Joint Interventions:

  • 37.0% decrease from 2019-2022, with a 14.3% geometric average annual change.

Audit Risk for Pain Physicians:

  • 90% of pain physicians will be audited within their first 10 years of practice.
  • Currently, over 40% of physicians are under active investigation for fraud and abuse.


Risk of Losing Appeals:

  • 90% of physicians may lose fraud and abuse appeals, even after meeting all LCD criteria.

Find the Answers to Your Questions!

Additional Info
Register today!

The cost of the webinar is $175 and will provide you with 2 AMA PRA Category 1 Credits™

 

CMS Releases Final 2025 Fee Schedule


CMS has finalized the 2025 Medicare Physician Fee Schedule, implementing a 2.83% cut to Medicare physician reimbursements, as previously outlined.


This cut continues a long trend of decreased reimbursements, originating with the Budget Control Act of 2011 under the Affordable Care Act. As a result, sequester cuts of 2% will remain in effect until 2032 unless Congress enacts a permanent fix to prevent these annual adjustments.


Impact on Interventional Pain Management (IPM) Services:

The final schedule reflects a 2.83% reduction in reimbursements for IPM services.


New Bipartisan Legislation Introduced to Counter Cuts:

Congressman Greg Murphy, M.D., has introduced a bipartisan bill to address this issue. This legislation aims to prevent the proposed reimbursement cut and introduce a payment increase (1.8%) equal to half of the Medicare Economic Index, aligning with recommendations from the Medicare Payment Advisory Commission.


The bill has garnered support from AMA, numerous organizations, including ASIPP. We encourage all members to act by contacting your congressman and senators to support this legislation.


Click here for the Physician Final Payment Rates


ASC:

There are no major changes for IPM procedures in ASC settings, aside from adjustments in specific codes. Notably, there is a 2% to 3% increase for codes 62361, 62360, 61885, 64590, and 62362, while codes 63688, 64595, 63664, 64585, 63662, 64569, 62350, and 64553 will see a 5% to 7% decrease.


Click here for the ASC Final Payment Rates


Click here for the HOPD Final Payment Rates

Abstract submissions are open for ASIPP's 2025 Annual Meeting!


The abstract submission deadline is March 10, 2025. 


Don't miss this opportunity to share your insights and

help shape the future of pain management.

Abstract Guidelines
Submit Abstract

House bill introduced to cancel Medicare cuts and give physicians a positive payment update for 2025



House members have introduced a measure to cancel the 2.8 percent Medicare cut and give physicians a positive Medicare payment update for next year, following AMA advocacy.


Bipartisan bill would stabilize Medicare physician pay for 2025.


Tell your Representative to cosponsor the Medicare Patient Access and Practice Stabilization Act (H.R. 10073)!


What’s the news

Following AMA advocacy in leading the charge to reform the Medicare payment system, a bipartisan group in the U.S. House of Representatives has introduced a bill that would provide a 4.7% payment update in 2025. The measure would eliminate the 2.8% Medicare physician payment cut slated for Jan. 1 and provide a positive payment update that is equal to one half of the Medicare Economic Index.


“The introduction today of a bill to stop the ruinous Medicare payment cut that is scheduled to go into effect Jan. 1 is a vital sign that Congress is poised to act. Lawmakers must take action during the lame-duck session,” AMA President Bruce A. Scott, MD, said in a statement, referring to the period of congressional activity after the November elections and preceding the start of next session of Congress in January.


The physician payment increase contained in the measure—H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024—is similar to the recommendation made by the Medicare Payment Advisory Commission. The bill was introduced by Reps. Greg Murphy (R-N.C.), and Jimmy Panetta (D-Calif.), along with several cosponsors. Visit the AMA’s Fix Medicare Now website to tell your representative to cosponsor the bill.


Read More

Support our Sponsor!



The Trouble With Upcoding Extends Far Beyond Ethics

The practice reminds us that our healthcare system is failing patients and clinicians alike




After a long day in my primary care practice in rural southwest Virginia, I still had one more task to complete. As an employee of a healthcare corporation that provided care for Medicare patients, I was required to review and add additional "suggested" diagnoses to each Medicare Advantage encounter.


I later learned that this practice, known as "upcoding," is a means to make patients appear "sicker" and thus increase the annual capitation payment that the Medicare Advantage plan receives to insure these patients. The extra revenues were then shared with our employer in the form of "bonuses." We were told that these payments would help keep our department solvent and that our compliance with this coding practice would be reflected in our compensation.


This practice seemed harmless enough. However, I later learned that upcoding is responsible for $12-25 billion in overpayments to Medicare Advantage insurers each year, enough to provide free vision and hearing care to every senior over age 65. I was involved in a practice that, at best, was billing in a way that increased our income a bit and, at worst, was defrauding taxpayers and contributing corporate profits to both insurers and healthcare companies. This was a moral dilemma that was quite different than those I studied in my medical school medical ethics class.


Read More


Real-World Data on the RSV Vaccine for Older Adults

"Remarkable" how closely effectiveness in real-world setting matches clinical trial efficacy



During last year's respiratory virus season, newly approved vaccines for respiratory syncytial virus (RSV) were effective in preventing associated hospitalizations and more serious outcomes in adults 60 and older, an analysis of electronic health records across eight states showed.


In immunocompetent individuals, adjusted vaccine effectiveness reached 80% (95% CI 71-85) against RSV-associated hospitalizations, 81% (95% CI 52-92) against associated critical illness (intensive care unit [ICU] admission, death, or both), and 77% (95% CI 70-83) against RSV-associated emergency department visits, reported Amanda Payne, PhD, of the CDC, and colleagues.


The vaccines showed a good amount of benefit in higher-risk groups as well, according to the findings in The Lancet.


Read More


Virtual

December 14


  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam



2025 Exam Dates Coming Soon!

Exam Dates

 



Continuous Glucose Monitors for All? Opinions Remain Mixed





The recent US Food and Drug Administration (FDA) clearance of two over-the-counter (OTC) continuous glucose monitors (CGMs) — Dexcom’s Stelo and Abbott’s Lingo — has sparked interest in potentially expanding their use to those without diabetes or prediabetes.


There are several valid questions about how the general population might benefit from CGMs. Can they motivate those struggling with overweight to shed pounds? Would they prompt users to follow more healthful eating patterns? Can they act as a canary in the coal mine, alerting users to prediabetes? 


The short answer to these questions is, we don’t know.


Read More

Registration is open for

ASIPP's 2025 Annual Meeting

We would love it if you would register and join us in Orlando!

Attendee Registration
Exhibitor Registration
Hotel Reservations
Exhibitor Prospectus




Medical Boards Barely Acted Amid Flood of COVID Misinformation





Only a handful of physicians in the five most populous states faced medical board discipline over spreading misinformation to the community during the height of the COVID-19 pandemic, a new study found.


In California, Texas, Florida, New York, and Pennsylvania, only six physicians were disciplined for disseminating medical misinformation in the first years of the pandemic, reported Richard S. Saver, JD, University of North Carolina School of Law and School of Medicine, Chapel Hill, in JAMA Network Open.


While the Federation of State Medical Boards had warned physicians that sharing misinformation could risk their licenses, “the study found extremely limited discipline for physicians spreading misinformation,” Saver told Medscape Medical News. “There does seem to be a very serious disconnect.”


Read More

- ASIPP Members Only Site Information -
  1. To log in for the first time you will need to click “forgot password” at the bottom of the login window.
  2. Check your email and then log in as directed.
  3. If you have problems logging into your account, click here.



Canadian Guideline on Managing Opioid Use Disorder Updated





Canada’s National Guideline for the Clinical Management of Opioid Use Disorder (OUD) has been updated to reflect the latest literature. The new document recommends buprenorphine and methadone as first-line treatments for OUD.


Opioid use and OUD remain the leading causes of drug-related death worldwide. In Canada, the number of apparent opioid-related deaths increased from 2831 in 2016 to 8049 in 2023. Despite the expansion of treatment options, including the lifting of restrictions on methadone prescribing in 2018, there has been a substantial surge in opioid-related harms, the authors wrote.


“OUD and opioid-related harms have devastating outcomes for our communities across Canada,” author Ginette Poulin, MD, a family physician at the University of Manitoba in Winnipeg, Manitoba, Canada, said in a statement. “With the growing dangers associated with the illicit market, we need to ensure we are sharing the most relevant therapeutic tools and up-to-date knowledge to help providers and communities address this complex issue.”


Read More

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

 

CASE REPORT

Dorsal Root Ganglion Stimulation as a Treatment for Chronic Refractory Groin Pain: A Case Series


Madhur Batra, MD, and Christopher J. Mallard, MD




Abstract

BACKGROUND: Complex regional pain syndrome (CRPS) can be a debilitating source of pain and is characterized by a combination of sensory, motor, vasomotor, and autonomic abnormalities. Neuromodulation can serve as a therapeutic intervention for groin CRPS.


CASE REPORT: Two patients with refractory CRPS in the groin and perineum underwent bilateral dorsal root ganglion (DRG) stimulation at L1 and S2. Both patients had reduction (> 70%) in their pain with lasting (> 6 months) relief.


CONCLUSIONS: CRPS can lead to changes in phenotype and function of the DRG. Stimulation of the DRG can block the passage of impulse trains where peripheral and central pathways of pain are modulated, resulting in improved symptoms and quality of life. Groin and perineal pain, refractory to conventional interventions, can be successfully treated with DRG stimulation.


KEY WORDS: Case report, complex regional pain syndrome, groin pain, dorsal root ganglion stimulation, neuromodulation


Read More

 

CROSS-SECTIONAL SURVEY

Single Institutional Cross-Sectional Phone Survey Study: Evaluation of Causes for Loss to Follow-up After Spinal Cord Stimulator Implantation


Kyle Kang, MD, Michael Glicksman, MD, Johnson Ho, MD, Kevin Hoang, MD, Anh Phung, MD, Sravya Madabhushi, MD, Jamal Hasoon, MD, Cyrus Yazdi, MD, Alexandra CG Fonseca, MD, Alan D. Kaye, MD, PhD, Michael E. Schatman, PhD, Jatinder Gill, MD, Thomas Simopoulos, MD, and Christopher L. Robinson, MD, PhD



Abstract

BACKGROUND: Spinal cord stimulation (SCS) is often an option of last resort for patients with post-laminectomy syndrome or an alternative option for patients with complex regional pain syndrome, chronic nonsurgical low back pain, or painful diabetic peripheral neuropathy when conservative management has failed. Although SCS is a helpful option, it is not without complications that can frequently lead to explantation of the SCS device and dissatisfaction with the treatment. Furthermore, as with any technology, SCS has potential issues that may lead to patient frustration and ultimately result in patient noncompliance and lack of follow-up visits.


OBJECTIVES: The goals of this study are to explore the magnitude of and reasons for patient loss to follow-up after SCS device implantation.


STUDY DESIGN: A cross-sectional phone survey.


SETTING: A tertiary-care academic hospital.


METHODS: A cross-sectional phone survey was performed on 49 patients who were deemed lost to follow-up when they did not return to the clinic one month after being implanted with permanent SCS devices at Beth Israel Deaconess Medical Center. Patients were administered an institutional review board-approved questionnaire exploring their reasons for not returning to the clinic.


RESULTS: Over a 5-year period, 257 patients underwent full implantation of an SCS device. Of the 49 patients lost to follow-up, 24 were able to be contacted, and they completed the questionnaire. Twenty of the patients continued to use the SCS device but were lost to follow-up for the following reasons: 58% (14/24) due to improvement of pain, 13% (3/24) due to minimal improvement in pain control, 4% (1/24) due to other urgent health conditions, and 8% (2/24) due to patient noncompliance and missing follow-up appointments (4/24). Four patients discontinued using the SCS device after an average of 1.5 years +/- one year, 12% (3/24) due to inadequate pain control and 4% (1/24) due to inability to recharge the device (1/24). Of these patients, 2 of the 4 contacted their SCS representatives for help with troubleshooting prior to discontinuation. None of the patients was explanted.


LIMITATIONS: The main limitation of this study was the incompletion rate, which was 51.0% (25 out of 49 patients).


CONCLUSIONS: This paper, the first cross-sectional study of loss to follow-up among patients who are implanted with SCS devices, identifies that up to 19% of patients are quickly lost to follow-up after implantation. Only half of the patients in this study could be reached, with most successfully using their device for meaningful pain control, but a substantial number of patients likely required additional device optimization for pain relief.


KEY WORDS: Loss to follow-up, spinal cord stimulation, cross-sectional study, phone survey, pain relief, single center, chronic pain, neuromodulation


Read More

DATA ANALYSIS

National and Geographic Trends in Medicare Reimbursement for Pain Management 2014-2023


George Wiest, BMus, Alexander Dorius, MBA, Carson Bateman, BS, and Miles Day, MD



Abstract

BACKGROUND: Increasing enrollment in Medicare has coincided with reductions in reimbursement for various procedures, including interventional pain procedures. No previous analysis of state-to-state differences in Medicare reimbursement rates for practicing pain management physicians has been performed.


OBJECTIVE: To quantify recent national and geographical trends for interventional pain procedures.


STUDY DESIGN: This study used datasets from the Centers for Medicare and Medicaid Services to identify the top 10 highest-grossing Current Procedure Terminology (CPT) codes for pain procedures and for evaluation and management (E/M) from 2014 to 2023. Data analysis took place during May 2023.


METHODS: Primary outcomes were calculated inflation-adjusted rates of yearly percent change (YPC) for each CPT code, state, territory, and U.S. Census region. An independent samples t-test compared the national YPC rates of procedure to those of E/M reimbursement. Medicare reimbursements throughout the United States for interventional pain procedures and clinic evaluations were measured from 2014-2023.


RESULTS: From 2014 to 2023, inflation-adjusted Medicare reimbursement for interventional pain procedures decreased yearly by an average of 3.63%. In comparison, clinic evaluation reimbursement decreased by only 0.87% yearly and was significantly different from procedure reimbursement (P < 0.001). Pain management procedure reimbursement decreased the most in Illinois (-4.26%), Wyoming (-3.88%), Wisconsin (-3.87%), Nevada (-3.83%) and Kansas (-3.82%). Meanwhile, rates for Puerto Rico (-1.94%), Massachusetts (-3.24%), Washington (-3.31%), New York (-3.39%), and West Virginia (-3.47%) decreased the least. When states were grouped into U.S. Census regions, no significant regional differences in pain management procedure reimbursement changes could be observed.


LIMITATIONS: Only the facility prices of the top 10 highest-grossing procedure and E/M CPT codes that had available data for 2014 to 2023 could be included in our analysis; trends for private insurance reimbursement could not be analyzed.


CONCLUSIONS: Medicare reimbursement rates for interventional pain procedures have decreased from 2014 to 2023, both nationally and in each region of the U.S. Our analysis suggests that certain states and territories have experienced less favorable reimbursement trends than others. This issue is worthy of attention as larger proportions of the U.S. population become eligible for Medicare coverage; should these trends continue, interventional pain physicians may consider moving their practices to areas that are less affected. Major efforts are required to preserve the quality of care that Medicare beneficiaries receive and to remedy the problem of depreciating reimbursement.


KEY WORDS: Medicare, reimbursement, pain management, health care policy, economics, physician fees, finance, GPCI, social determinants of health


Read More

 



ASIPP is now in collaboration with Curi Medical Liability Program


Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More

 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.


We have received a tremendous amount of interest in the ASIPP billing and coding program.


Click here to learn more about the negotiated rate for practices and more!

Like and follow ASIPP® on Facebook, X, and LinkedIn for the most

up-to-date news related to you, your practice, and your patients!